Aptevo Therapeutics Inc. Restricted Cash, Noncurrent
Aptevo Therapeutics Inc. (APVO) had Restricted Cash, Noncurrent of $693.00 thousand as of 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2021-03-31
- 2020-06-30: Restricted Cash, Noncurrent $693.00K.
- 2020-03-31: Restricted Cash, Noncurrent $2.53M.
- 2019-12-31: Restricted Cash, Noncurrent $7.50M.
- 2019-09-30: Restricted Cash, Noncurrent $7.50M.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2020-06-30 | $693.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $2.53M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $7.50M 10-K · filed 2021-03-31 |
| 2019-09-30 | $7.50M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $7.50M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $7.45M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $7.45M 10-K · filed 2020-03-25 |
| 2018-09-30 | $7.45M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $12.45M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $11.24M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $10.00M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |